Daiichi Sankyo, Inc.

Oladayo Oyelola, PhD, SC (ASCP)

Director, Clinical Trial Information Disclosure, Regulatory Management Operations
Daiichi Sankyo, Inc.

Dr. Oladayo Oyelola is Director, Clinical Trial Information Disclosure at Daiichi Sankyo, Inc. He is responsible for corporate strategy and operations of global clinical trial information disclosure and clinical data sharing compliance activities. He also manages and coordinates internal trial disclosure operations’ training, process improvements and clinical trial transparency regulatory policy intelligence. 

He has also served in the same capacity and as Head of the R&D Clinical Medical Writing Platform at Sanofi Pasteur Inc., the Vaccine Division of Sanofi during which he led regulatory medical writing activities on clinical projects and clinical study teams for novel vaccine and pharmaceutical products for the US, EU and other international regulatory submissions and marketing approvals.

Dr. Oyelola holds a BS degree in Biochemistry, MS in Applied (Nutrition) Chemistry, and PhD degree in Clinical Chemistry. 

He was a recipient of The Rockefeller Foundation Special Postdoctoral Fellowship Award with tenure at the University of Cincinnati and Cardiovascular Research Center 1991 – 1993; and the National Mentor Role Model Award/Citation of the Minority Access Inc. / Office of Minority Health, National Institutes of Health in 2001.

He has over 30 years’ experience in clinical and pharmaceutical research and development activities along with professional certifications of the National Registry of Certified Chemists and the American Society for Clinical Pathologists.

He is a member of the American Association for Clinical Chemists, the American Society for Clinical Pathology, and the Drug Information Association.

Oladayo Oyelola, PhD, SC (ASCP)’s Session(s)

— 12:15 pm
Trial Protocols to Impact Registries and Regulations

Copyright © 2024 Lincoln Health Network | Terms and Conditions | Privacy Policy